Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Did Phio Pharmaceuticals Beat Earnings?

Phio Pharmaceuticals (PHIO) reported Q2 '26 revenue of $0.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Phio Pharmaceuticals’s job postings, web traffic, and employee business outlook. See the full PHIO stock analysis or the earnings calendar for upcoming reports.

Phio Pharmaceuticals Quarterly Financial Trends ()

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue—70,000——————
Gross margin—-1,407.1%——————
Operating margin—-2,391.4%——————
Net income-1.5M-1.6M-1.8M-2.2M-2.4M-2.4M-4M-4.1M
Net margin—-2,322.9%——————
EPS————————

Phio Pharmaceuticals Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Phio Pharmaceuticals’s quarterly revenue moved from $0 to $0.

When Is Phio Pharmaceuticals’s Next Earnings Date?

Phio Pharmaceuticals reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the PHIO earnings calendar.

Frequently Asked Questions: Phio Pharmaceuticals Earnings

Phio Pharmaceuticals's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Phio Pharmaceuticals reported Q2 '26 revenue of $0.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the PHIO AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.